Anne R. Mason

Publications and Insights

• Publication: Patient preferences for treatment in relapsed/refractory acute leukemia
• Publication: Understanding the preferences of people with acute leukemia for different health outcomes
• Publication: Altering the trajectory of HIV in Europe
• Insight: GLP-1 Receptor Agonists: Shifting Obesity Management
• Publication: Understanding societal preferences for priority by disease severity in England & Wales
• Insight: Kahneman’s legacy in health economics
• Insight: NICE’s severity modifier: a step in the right direction, but still a long way to go
• Insight: Including Carer Quality of Life in Health Technology Evaluation: Are We There Yet?
• Publication: When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies
• Publication: How is Quality of Life Measured for Health Technology Assessments?
• Publication: Resource Allocation in Public Sector Programmes: Does the Value of a Life Differ Between Governmental Departments?
• Publication: Using QALYs in Cancer: Review of the Methodological Limitations
• Publication: Assessment and Appraisal of Oncology Medicines: NICE’s Approach and International HTA Experience
• Publication: Economic Post-Launch Studies: Matching the Desirable with the Feasible
• Publication: To Publish or Not: Experience and Evidence About Publishing Hospital Outcomes Data
• Publication: Influencing Prescribing in a Primary Care Led NHS
• Publication: Disease Management, the NHS and the Pharmaceutical Industry
• Publication: The Ideas and Influence of Alan Williams: Be Reasonable – Do It My Way